JBCHEPHARM — J B Chemicals and Pharmaceuticals Income Statement
0.000.00%
Last trade - 00:00
- IN₹293.30bn
- IN₹293.36bn
- IN₹31.49bn
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 16,432 | 17,747 | 20,425 | 24,242 | 31,493 |
Cost of Revenue | |||||
Gross Profit | 9,586 | 10,589 | 12,625 | 14,894 | 18,729 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 13,846 | 14,667 | 15,550 | 19,496 | 25,569 |
Operating Profit | 2,586 | 3,080 | 4,875 | 4,746 | 5,924 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 2,870 | 3,489 | 5,969 | 5,049 | 5,552 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1,940 | 2,707 | 4,485 | 3,860 | 4,100 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 1,935 | 2,720 | 4,480 | 3,854 | 4,098 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1,935 | 2,720 | 4,480 | 3,854 | 4,098 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 11.7 | 17.4 | 26.4 | 24.8 | 26.2 |
Dividends per Share |